| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 11 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | China | 3 | |
| #5 | Australia | 1 | |
| #6 | Canada | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Liu Bo | 25 |
| #2 | Sheng Jackie | 19 |
| #3 | Karow Margaret | 12 |
| #4 | Zhang Wei | 9 |
| #5 | Sheng Jackie Z | 9 |
| #6 | Jia Haiqun | 5 |
| #7 | Truong Khue | 5 |
| #8 | Loucks Emily | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020263312A1 | ANTITUMOR ANTAGONIST CONSISTING OF A MUTATED TGFβ1 - RII EXTRACELLULAR DOMAIN AND AN IMMUNOGLOBULIN SCAFFOLD | |
| EP3814381A1 | Trispecific antagonists | |
| WO2018128939A1 | Checkpoint regulator antagonists | |
| EP3432927A1 | Trispecific inhibitors for cancer treatment |